Dingkong Liang

1.4k total citations
21 papers, 1.1k citations indexed

About

Dingkong Liang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Dingkong Liang has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Dingkong Liang's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Dingkong Liang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Dingkong Liang collaborates with scholars based in China and United States. Dingkong Liang's co-authors include Si Shi, Jin Xu, Xianjun Yu, Chen Liang, Quanxing Ni, Shunrong Ji, Yi Qin, Qingcai Meng, Wenyan Xu and Bo Zhang and has published in prestigious journals such as Oncogene, Annals of Surgery and Clinical Cancer Research.

In The Last Decade

Dingkong Liang

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dingkong Liang China 18 634 573 439 145 140 21 1.1k
Massimo Pancione Italy 21 659 1.0× 427 0.7× 370 0.8× 135 0.9× 88 0.6× 48 1.2k
Yitian Chen China 18 583 0.9× 466 0.8× 424 1.0× 223 1.5× 113 0.8× 45 1.3k
Wenhui Lou China 19 418 0.7× 582 1.0× 388 0.9× 180 1.2× 233 1.7× 62 1.1k
Basil Bakir United States 7 575 0.9× 476 0.8× 325 0.7× 142 1.0× 97 0.7× 12 981
Elisabeth Heßmann Germany 17 773 1.2× 750 1.3× 305 0.7× 105 0.7× 153 1.1× 39 1.3k
Cecilia Lau Hong Kong 12 692 1.1× 391 0.7× 495 1.1× 124 0.9× 110 0.8× 14 1.5k
Aline Meulle France 9 671 1.1× 553 1.0× 607 1.4× 96 0.7× 87 0.6× 12 1.4k
Yan‐Miao Huo China 21 559 0.9× 534 0.9× 435 1.0× 184 1.3× 150 1.1× 54 1.2k
Masahisa Ohkuma Japan 11 488 0.8× 737 1.3× 335 0.8× 87 0.6× 168 1.2× 40 1.1k

Countries citing papers authored by Dingkong Liang

Since Specialization
Citations

This map shows the geographic impact of Dingkong Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingkong Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingkong Liang more than expected).

Fields of papers citing papers by Dingkong Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingkong Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingkong Liang. The network helps show where Dingkong Liang may publish in the future.

Co-authorship network of co-authors of Dingkong Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Dingkong Liang. A scholar is included among the top collaborators of Dingkong Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingkong Liang. Dingkong Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Jinfeng, Qiangsheng Hu, Yi Qin, et al.. (2018). TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer. Cell Death and Disease. 9(3). 321–321. 46 indexed citations
2.
Meng, Qingcai, Si Shi, Chen Liang, et al.. (2018). Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling. Oncogene. 37(44). 5843–5857. 99 indexed citations
3.
Liang, Dingkong, Si Shi, Chen Liang, et al.. (2018). Mismatch repair status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for pancreatic cancer. Surgery. 163(5). 1080–1089. 3 indexed citations
4.
Hua, Jie, Si Shi, Dingkong Liang, et al.. (2018). Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?. OncoTargets and Therapy. Volume 11. 4591–4608. 7 indexed citations
5.
Liang, Chen, Si Shi, Qingcai Meng, et al.. (2018). MiR‐29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125. International Journal of Cancer. 143(11). 2919–2931. 23 indexed citations
6.
Liang, Chen, Yi Qin, Bo Zhang, et al.. (2017). Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Research. 15(2). 201–212. 46 indexed citations
7.
Hu, Qiangsheng, Yi Qin, Bo Zhang, et al.. (2017). FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1. Oncology Reports. 38(4). 2069–2077. 26 indexed citations
8.
Liang, Chen, Si Shi, Qingcai Meng, et al.. (2017). Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going. Experimental & Molecular Medicine. 49(12). e406–e406. 121 indexed citations
9.
Liu, Wensheng, Bo Zhang, Qiangsheng Hu, et al.. (2017). A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism. International Journal of Oncology. 50(5). 1792–1800. 22 indexed citations
10.
Liang, Chen, Si Shi, Qingcai Meng, et al.. (2017). Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?. Cellular and Molecular Life Sciences. 75(6). 1001–1012. 32 indexed citations
11.
Meng, Qingcai, Si Shi, Chen Liang, et al.. (2017). Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis. Journal of Cancer. 8(17). 3615–3622. 27 indexed citations
12.
Meng, Qingcai, Si Shi, Chen Liang, et al.. (2017). Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis. OncoTargets and Therapy. Volume 10. 4591–4598. 110 indexed citations
13.
Ji, Shunrong, Yi Qin, Chen Liang, et al.. (2016). FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer. Clinical Cancer Research. 22(15). 3950–3960. 76 indexed citations
14.
Xiang, Jinfeng, Si Shi, & Dingkong Liang. (2016). Recent advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2015. Zhongguo aizheng zazhi. 26(4). 281–289.
15.
Liang, Dingkong, Si Shi, Jin Xu, et al.. (2016). New insights into perineural invasion of pancreatic cancer: More than pain. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1865(2). 111–122. 54 indexed citations
16.
Liang, Chen, Yi Qin, Bo Zhang, et al.. (2016). ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer. Cancer Letters. 388. 303–311. 45 indexed citations
17.
Liang, Chen, Yi Qin, Bo Zhang, et al.. (2016). Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1866(2). 177–188. 33 indexed citations
18.
Liang, Chen, Yi Qin, Bo Zhang, et al.. (2016). Energy sources identify metabolic phenotypes in pancreatic cancer. Acta Biochimica et Biophysica Sinica. 48(11). 969–979. 29 indexed citations
19.
Ji, Shunrong, Bo Zhang, Jiang Liu, et al.. (2016). ALDOA functions as an oncogene in the highly metastatic pancreatic cancer. Cancer Letters. 374(1). 127–135. 110 indexed citations
20.
Ji, Shunrong, Yi Qin, Si Shi, et al.. (2015). ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer. Cell Research. 25(5). 561–573. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Pancione Breakdown of academic impact, for papers by Yitian Chen Breakdown of academic impact, for papers by Wenhui Lou Breakdown of academic impact, for papers by Basil Bakir Breakdown of academic impact, for papers by Elisabeth Heßmann Breakdown of academic impact, for papers by Cecilia Lau Breakdown of academic impact, for papers by Aline Meulle Breakdown of academic impact, for papers by Yan‐Miao Huo Breakdown of academic impact, for papers by Masahisa Ohkuma
Rankless by CCL
2026